SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-16-009186
Filing Date
2016-04-26
Accepted
2016-04-26 17:00:55
Documents
11
Period of Report
2016-04-25
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm 8-K 55403
2 ex10-1.htm EX-10.1 139760
3 ex10-2.htm EX-10.2 65222
4 ex10-3.htm EX-10.3 44372
5 ex10-4.htm EX-10.4 138628
6 ex10-5.htm EX-10.5 67959
7 ex10-6.htm EX-10.6 42671
8 ex10-7.htm EX-10.7 136125
9 ex10-8.htm EX-10.8 42469
10 ex10-3.jpg GRAPHIC 4154
11 image_001.jpg GRAPHIC 9042
  Complete submission text file 0001493152-16-009186.txt   752458
Mailing Address 12264 EL CAMINO REAL SUITE 350 SAN DIEGO CA 92130
Business Address 12264 EL CAMINO REAL SUITE 350 SAN DIEGO CA 92130 858-704-4042
Imprimis Pharmaceuticals, Inc. (Filer) CIK: 0001360214 (see all company filings)

IRS No.: 450567010 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35814 | Film No.: 161592595
SIC: 2834 Pharmaceutical Preparations